205 related articles for article (PubMed ID: 24718862)
1. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
[TBL] [Abstract][Full Text] [Related]
2. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
5. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
6. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
9. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
[TBL] [Abstract][Full Text] [Related]
10. Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases.
Conill C; Jorcano S; Domingo-Doménech J; Gallego R; Malvehy J; Puig S; Sánchez M; Vilella R; Castel T
Clin Transl Oncol; 2006 Apr; 8(4):266-70. PubMed ID: 16648102
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of temozolomide plus whole-brain radiotherapy in the treatment of intracranial metastases.
Liu HP; Zheng KB; Wang JW
J Cancer Res Ther; 2017; 13(5):785-789. PubMed ID: 29237904
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
[TBL] [Abstract][Full Text] [Related]
13. The benefit of whole brain reirradiation in patients with multiple brain metastases.
Ozgen Z; Atasoy BM; Kefeli AU; Seker A; Dane F; Abacioglu U
Radiat Oncol; 2013 Jul; 8():186. PubMed ID: 23879889
[TBL] [Abstract][Full Text] [Related]
14. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
15. Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysis.
Han J; Qiu M; Su L; Wu C; Cheng S; Zhao Z; Li D; Wang M; Tao W; Du S
Thorac Cancer; 2021 Dec; 12(23):3177-3183. PubMed ID: 34704360
[TBL] [Abstract][Full Text] [Related]
16. Analysis of outcome in patients reirradiated for brain metastases.
Wong WW; Schild SE; Sawyer TE; Shaw EG
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):585-90. PubMed ID: 8621282
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD
Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
Abrey LE; Olson JD; Raizer JJ; Mack M; Rodavitch A; Boutros DY; Malkin MG
J Neurooncol; 2001 Jul; 53(3):259-65. PubMed ID: 11718258
[TBL] [Abstract][Full Text] [Related]
19. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.
Ren Y; Wang SB; Zhou L; Liu SQ; Du LY; Li T; Jiang MQ; Lei KJ; Tan BX; Jia YM
Technol Cancer Res Treat; 2021; 20():15330338211011968. PubMed ID: 33955301
[TBL] [Abstract][Full Text] [Related]
20. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
Pesce GA; Klingbiel D; Ribi K; Zouhair A; von Moos R; Schlaeppi M; Caspar CB; Fischer N; Anchisi S; Peters S; Cathomas R; Bernhard J; Kotrubczik NM; D'Addario G; Pilop C; Weber DC; Bodis S; Pless M; Mayer M; Stupp R
Eur J Cancer; 2012 Feb; 48(3):377-84. PubMed ID: 22093943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
